RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Charles River Laboratories International - Stock

Charles River Laboratories International P/E 2024

Charles River Laboratories International P/E

18.67

Ticker

CRL

ISIN

US1598641074

WKN

939391

As of Jun 18, 2024, Charles River Laboratories International's P/E ratio was 18.67, a -12.27% change from the 21.28 P/E ratio recorded in the previous year.

The Charles River Laboratories International P/E history

Charles River Laboratories International Aktienanalyse

What does Charles River Laboratories International do?

Charles River Laboratories International Inc. is a global company in the field of life sciences. It offers a wide range of products and services to support drug development and patient care. The company started as a supplier of laboratory animals in 1947 and expanded into the field of toxicology in the 1960s. It is now a leading provider of preclinical studies and tests. Charles River operates in North America, Europe, and Asia, with over 80 facilities and more than 17,000 employees. Its main business model is supporting drug manufacturers and biotechnology companies in the development, testing, and approval of new medications. The company also offers products for research projects, including animal models, cell cultures, and antibodies. Charles River has five main business areas: Early Discovery, Safety Assessment, Biologics Testing Solutions, Biomedical Research Models, and Genetically Engineered Models. Each of these areas focuses on a specific task or market. In addition to these main areas, Charles River also provides tailored services, such as consulting, training, and support, to meet the specific needs of its customers. The company is dedicated to improving the health and well-being of humans and animals and continually strives to enhance the quality of its products and services. Charles River Laboratories International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Charles River Laboratories International's P/E Ratio

The Price to Earnings (P/E) Ratio of Charles River Laboratories International is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Charles River Laboratories International's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Charles River Laboratories International is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Charles River Laboratories International’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Charles River Laboratories International Stock

What is the price-to-earnings ratio of Charles River Laboratories International?

The price-earnings ratio of Charles River Laboratories International is currently 18.67.

How has the price-earnings ratio of Charles River Laboratories International changed compared to last year?

The price-to-earnings ratio of Charles River Laboratories International has increased by -12.27% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Charles River Laboratories International high compared to other companies?

Yes, the price-to-earnings ratio of Charles River Laboratories International is high compared to other companies.

How does an increase in the price-earnings ratio of Charles River Laboratories International affect the company?

An increase in the price-earnings ratio of Charles River Laboratories International would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Charles River Laboratories International affect the company?

A decrease in the price-earnings ratio of Charles River Laboratories International would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Charles River Laboratories International?

Some factors that influence the price-earnings ratio of Charles River Laboratories International are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Charles River Laboratories International pay?

Over the past 12 months, Charles River Laboratories International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Charles River Laboratories International is expected to pay a dividend of 0 USD.

What is the dividend yield of Charles River Laboratories International?

The current dividend yield of Charles River Laboratories International is .

When does Charles River Laboratories International pay dividends?

Charles River Laboratories International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Charles River Laboratories International?

Charles River Laboratories International paid dividends every year for the past 0 years.

What is the dividend of Charles River Laboratories International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Charles River Laboratories International located?

Charles River Laboratories International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Charles River Laboratories International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Charles River Laboratories International from 6/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/18/2024.

When did Charles River Laboratories International pay the last dividend?

The last dividend was paid out on 6/18/2024.

What was the dividend of Charles River Laboratories International in the year 2023?

In the year 2023, Charles River Laboratories International distributed 0 USD as dividends.

In which currency does Charles River Laboratories International pay out the dividend?

The dividends of Charles River Laboratories International are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Charles River Laboratories International stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Charles River Laboratories International

Our stock analysis for Charles River Laboratories International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Charles River Laboratories International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.